AIMDW
Ainos, Inc. NASDAQ$0.11
Mkt Cap $470,940
52w Low $0.05
49.2% of range
52w High $0.17
50d MA $0.12
200d MA $0.16
P/E (TTM)
-0.0x
EV/EBITDA
-1.9x
P/B
0.1x
Debt/Equity
1.4x
ROE
-195.3%
P/FCF
-1.5x
RSI (14)
—
ATR (14)
—
Beta
2.32
50d MA
$0.12
200d MA
$0.16
Avg Volume
4.7K
About
Ainos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nuclei…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | 1M% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 30, 2026 | AMC | — | -2.08 | — | 0.11 | +2.0% | +2.0% | -11.2% | -11.2% | -11.2% | -11.2% | -22.0% | — |
| Sep 30, 2023 | AMC | — | -0.15 | — | — | — | — | — | — | — | — | — | — |
| Jun 30, 2023 | AMC | — | -0.12 | — | 0.29 | -33.8% | -18.5% | -13.1% | -8.4% | -2.4% | — | -26.8% | — |
| Mar 31, 2023 | AMC | — | -0.13 | — | — | — | — | — | — | — | — | — | — |
| Dec 31, 2022 | AMC | — | -0.16 | — | — | — | — | — | — | — | — | — | — |
Data updated apr 28, 2026 1:05am
· Source: massive.com